Viewing Study NCT02335853



Ignite Creation Date: 2024-05-06 @ 3:36 AM
Last Modification Date: 2024-10-26 @ 11:36 AM
Study NCT ID: NCT02335853
Status: UNKNOWN
Last Update Posted: 2015-01-12
First Post: 2015-01-02

Brief Title: Association Between Metabolic Syndrome and Serum Nerve Growth Factor Levels in Women With Overactive Bladder
Sponsor: Bakirkoy Dr Sadi Konuk Research and Training Hospital
Organization: Bakirkoy Dr Sadi Konuk Research and Training Hospital

Study Overview

Official Title: Association Between Metabolic Syndrome and Serum Nerve Growth Factor Levels in Women With Overactive Bladder
Status: UNKNOWN
Status Verified Date: 2015-01
Last Known Status: RECRUITING
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: NGF
Brief Summary: Nerve growth factor NGF-R receptors are between the detrusor muscle fibers and can cause afferent signals Metabolic syndrome and obesity have been advocated to be risk factors for the development of overactive bladder
Detailed Description: Overactive bladder is a clinical syndrome characterized urgency frequency and nocturia Infection or other obvious causes must be excluded The overactive bladder is loss of inhibition of the detrusor muscle during the filling or emptying of the bladder

Specific receptors and neurotransmitters have role in development of overactive bladder These includes adrenergic cholinergic non-adrenergic non-cholinergic receptors and interstitial cells

Nerve growth factor NGF-R receptors are between the detrusor muscle fibers and can cause afferent signals Metabolic syndrome and obesity have been advocated to be risk factors for the development of overactive bladder The investigators believe that our findings will shed light on treatment

Study Oversight

Has Oversight DMC: None
Is a FDA Regulated Drug?: None
Is a FDA Regulated Device?: None
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: None